Physician profile
Stephen L Sinoway
NPI 1578569737
$1,576.33
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $287 · 2020: $56.48 · 2021: $171 · 2022: $333 · 2023: $405 · 2024: $324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $729.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $729.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $364.61 | 2019-2024 | Precision 1, Dailies Total1, Dailies |
| Coopervision INC. | $298.91 | 2019-2024 | Myday Contact Lens, Clariti Contact Lens |
| Johnson & Johnson Vision Care, INC. | $167.06 | 2019-2024 | Acuvue |
| Oyster Point Pharma, INC. | $123.32 | 2022-2024 | Tyrvaya |
| Rxsight INC | $121.37 | 2023 | Rxsight Light Adjustable Lens (Rxlal), Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $99.09 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $95.96 | 2020-2024 | Cequa |
| Bausch & Lomb Americas INC. | $91.80 | 2022-2024 | Infuse, Xiidra, Miebo |
| Visioneering Technologies, INC. | $39.86 | 2019 | |
| Kala Pharmaceuticals, INC. | $38.41 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $33.98 | 2021-2023 | |
| Allergan, INC. | $29.50 | 2021 | |
| Abb Con-Cise Optical Group LLC | $24.71 | 2019-2020 | |
| Tarsus Pharmaceuticals, INC. | $16.46 | 2024 | Xdemvy |
| Dompe US, INC. | $16.38 | 2024 | Oxervate |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $14.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Sinoway listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.